XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $384,346 | -9.2% | 9,983 | -15.6% | 0.01% | -11.1% |
Q1 2023 | $423,217 | -9.2% | 11,825 | 0.0% | 0.01% | -18.2% |
Q4 2022 | $466,260 | +9.2% | 11,825 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $427,000 | -46.6% | 11,825 | -55.0% | 0.01% | -47.6% |
Q2 2022 | $800,000 | +7.5% | 26,306 | +8.1% | 0.02% | +23.5% |
Q1 2022 | $744,000 | +29.6% | 24,326 | +32.4% | 0.02% | +21.4% |
Q4 2021 | $574,000 | -70.9% | 18,376 | -85.7% | 0.01% | -74.5% |
Q3 2021 | $1,970,000 | -8.8% | 128,924 | +11.1% | 0.06% | -20.3% |
Q2 2021 | $2,161,000 | +32.9% | 116,057 | +27.8% | 0.07% | +13.1% |
Q1 2021 | $1,626,000 | +148.6% | 90,816 | +113.6% | 0.06% | +154.2% |
Q4 2020 | $654,000 | +61.9% | 42,513 | +16.4% | 0.02% | 0.0% |
Q3 2020 | $404,000 | -27.9% | 36,518 | -18.3% | 0.02% | -36.8% |
Q2 2020 | $560,000 | -24.0% | 44,685 | -31.2% | 0.04% | -37.7% |
Q1 2020 | $737,000 | +10.2% | 64,989 | +27.4% | 0.06% | +5.2% |
Q4 2019 | $669,000 | +45.4% | 51,007 | 0.0% | 0.06% | +38.1% |
Q3 2019 | $460,000 | -9.8% | 51,007 | -1.5% | 0.04% | -8.7% |
Q2 2019 | $510,000 | -32.3% | 51,772 | -30.2% | 0.05% | -37.0% |
Q1 2019 | $753,000 | +243.8% | 74,162 | +113.8% | 0.07% | +128.1% |
Q4 2018 | $219,000 | -13.8% | 34,682 | +79.9% | 0.03% | +28.0% |
Q3 2018 | $254,000 | -21.8% | 19,275 | -45.4% | 0.02% | -10.7% |
Q2 2018 | $325,000 | – | 35,319 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |